P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR

• Othman Al-Sawaf,
• Min-Hua Jen,
• Lisa Hess,
• Jiewen Zhang,
• Benjamin Goebel,
• John Pagel,
• Toby Eyre

Affiliations

Othman Al-Sawaf

1 University Hospital, Cologne, Germany

Min-Hua Jen

2 Eli Lilly and Company Corporate Center, Erlwood, United Kingdom

Lisa Hess

3 Eli Lilly and Company Corporate Center, Indianapolis, United States

Jiewen Zhang

4 TechData Service Company, King of Prussia, United States

Benjamin Goebel

5 Eli Lilly and Company, Bad Homburg, Germany

John Pagel

6 Loxo@Lilly, Indianapolis, United States

Toby Eyre

7 Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom